How would you manage a patient with history of locally advanced SCC of the cervix, treated with definitive chemoRT, found to have new lung lesions 6 months post treatment?  

All patients with metastatic cervical cancer should first be considered for a clinical trial. This is a condition with limited effective treatment options and also disproportionately affects younger women. It is pivotal clinicians be aware of the rapidly evolving landscape of clinical therapies for ...

If clinical and functional status allows it, I would treat with carbo/taxol/bev and consider maintenance Bev. In the meantime, I would ask for PDL-1 tumor testing for possible immunotherapy.